Literature DB >> 10190880

Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance.

G Jacob1, J R Shannon, F Costa, R Furlan, I Biaggioni, R Mosqueda-Garcia, R M Robertson, D Robertson.   

Abstract

BACKGROUND: Chronic orthostatic intolerance (OI) is characterized by symptoms of inadequate cerebral perfusion with standing, in the absence of significant orthostatic hypotension. A heart rate increase of >/=30 bpm is typical. Possible underlying pathophysiologies include hypovolemia, partial dysautonomia, or a primary hyperadrenergic state. We tested the hypothesis that patients with OI have functional abnormalities in autonomic neurons regulating cardiovascular responses. METHODS AND
RESULTS: Thirteen patients with chronic OI and 10 control subjects underwent a battery of autonomic tests. Systemic norepinephrine (NE) kinetics were determined with the patients supine and standing before and after tyramine administration. In addition, baroreflex sensitivity, hemodynamic responses to bolus injections of adrenergic agonists, and intrinsic heart rate were determined. Resting supine NE spillover and clearance were similar in both groups. With standing, patients had a greater decrease in NE clearance than control subjects (55+/-5% versus 30+/-7%, P<0.02). After tyramine, NE spillover did not change significantly in patients but increased 50+/-10% in control subjects (P<0.001). The dose of isoproterenol required to increase heart rate 25 bpm was lower in patients than in control subjects (0.5+/-0.05 versus 1.0+/-0.1 microg, P<0.005), and the dose of phenylephrine required to increase systolic blood pressure 25 mm Hg was lower in patients than control subjects (105+/-11 versus 210+/-12 microg, P<0.001). Baroreflex sensitivity was lower in patients (12+/-1 versus 18+/-2 ms/mm Hg, P<0.02), but the intrinsic heart rate was similar in both groups.
CONCLUSIONS: The decreased NE clearance with standing, resistance to the NE-releasing effect of tyramine, and increased sensitivity to adrenergic agonists demonstrate dramatically disordered sympathetic cardiovascular regulation in patients with chronic OI.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 10190880     DOI: 10.1161/01.cir.99.13.1706

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Authors:  T Pérez; B Tijero; I Gabilondo; A Luna; V Llorens; K Berganzo; M Acera; A Gonzalez; A Sanchez-Ferro; E Lezcano; J J Zarranz; J C Gómez-Esteban
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

2.  Postural orthostatic tachycardia syndrome and general anesthesia: a series of 13 cases.

Authors:  Jennifer A Rabbitts; Cornelius B Groenewald; Adam K Jacob; Phillip A Low; Timothy B Curry
Journal:  J Clin Anesth       Date:  2011-08       Impact factor: 9.452

3.  Postural orthostatic tachycardia syndrome.

Authors:  Una Graham; Kate M Ritchie
Journal:  BMJ Case Rep       Date:  2009-04-20

4.  Unusual cause of acquired brain injury.

Authors:  S D Pande; J Tan; S Lee
Journal:  BMJ Case Rep       Date:  2011-07-15

5.  Cerebrovascular and cardiovascular responses associated with orthostatic intolerance and tachycardia.

Authors:  M P Harms; J J van Lieshout
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

6.  Vagal and Sympathetic Function in Neuropathic Postural Tachycardia Syndrome.

Authors:  Giris Jacob; Laura Diedrich; Kyoko Sato; Robert J Brychta; Satish R Raj; David Robertson; Italo Biaggioni; André Diedrich
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

7.  Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome.

Authors:  Marvin S Medow; Christopher T Minson; Julian M Stewart
Journal:  Circulation       Date:  2005-10-17       Impact factor: 29.690

8.  Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome.

Authors:  Vegard Bruun Wyller; J Philip Saul; Lars Walløe; Erik Thaulow
Journal:  Eur J Appl Physiol       Date:  2007-12-08       Impact factor: 3.078

9.  Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.

Authors:  Ashley L Wagoner; Hossam A Shaltout; John E Fortunato; Debra I Diz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

Review 10.  Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment.

Authors:  Mohammed Ruzieh; Blair P Grubb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.